在匈牙利,肥胖的经济负担
Annals of nutrition & metabolism
|September 15, 2025
概括
2019年和2022年,匈牙利与肥胖相关的医疗保健费用大幅增加,影响了公共支出和患者共同支付. 有针对性的公共卫生政策和教育对于减少这些重大经济负担至关重要.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 肥胖对公众健康构成重大威胁,并因相关并发症而产生重大经济成本.
- 与肥胖相关的并发症 (ORCs) 导致医疗保健利用率和支出增加.
研究的目的:
- 计算匈牙利2019年和2022年与肥胖相关的公共支出.
- 估计COVID-19大流行之前和之后与肥胖相关的医疗保健成本的患者贡献.
主要方法:
- 关于肥胖患者支出的数据来自国家健康保险基金数据库.
- 财务信息包括住院/门诊服务,药品和治疗辅助工具的报销.
主要成果:
- 与肥胖相关的疾病占公共卫生保健病例的10-12%.
- 针对肥胖症的国家公共卫生保健费用约为1440亿法郎 (2019年) 和1330亿法郎 (2022年).
- 患者共同支付的费用估计为340亿法郎 (2019年) 和430亿法郎 (2022年),其中2型糖尿病和高血压是最昂贵的疾病.
结论:
- 减少与肥胖相关的支出需要有效的教育和公共卫生政策,以预防和控制体重.
- 需要标准化的国际方法来进行一致的肥胖成本计算.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
